Ligand Pharmaceuticals (LGND) Stock Chart & Stock Price History $99.60 -3.52 (-3.41%) As of 03:16 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Ligand Pharmaceuticals Stock Price Performance 5 Day Performance-9.50%1 Month Performance-15.50%3 Month Performance-11.90%6 Month Performance-7.04%Year-To-Date Performance-9.10%1 Year Performance+24.90% Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address LGND Stock Chart for Friday, April, 4, 2025 LGND Chart by TradingViewRemove Ads Ligand Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/03/2025$108.73$103.11-5.17%$106.63$101.73115,281 shs$1.99 billion04/02/2025$104.82$108.73+3.73%$108.77$102.60129,981 shs$2.09 billion04/01/2025$105.14$104.82-0.30%$107.49$102.5097,782 shs$2.02 billion03/31/2025$107.62$105.14-2.30%$106.37$103.06153,429 shs$2.02 billion03/28/2025$109.70$107.62-1.90%$109.82$106.4368,270 shs$2.07 billion03/27/2025$108.09$109.70+1.49%$112.49$107.61131,164 shs$2.11 billion03/26/2025$109.69$108.09-1.46%$111.52$107.6186,333 shs$2.08 billion03/25/2025$111.67$109.69-1.77%$112.53$109.36164,799 shs$2.11 billion03/24/2025$108.15$111.67+3.25%$112.61$108.8896,800 shs$2.15 billion03/21/2025$109.41$108.15-1.15%$111.86$106.79280,792 shs$2.08 billion Get the Latest News and Ratings for LGND and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 03/20/2025$108.03$109.41+1.28%$110.73$106.8794,797 shs$2.11 billion03/19/2025$106.22$108.03+1.70%$109.08$105.24125,065 shs$2.08 billion03/18/2025$109.95$106.22-3.39%$108.13$103.53128,585 shs$2.05 billion03/17/2025$106.19$109.95+3.54%$112.98$104.84166,965 shs$2.12 billion03/14/2025$105.62$106.19+0.54%$109.25$105.23147,291 shs$2.04 billion03/13/2025$108.09$105.62-2.29%$109.27$103.43120,884 shs$2.03 billion03/12/2025$105.79$108.09+2.17%$111.22$106.00191,463 shs$2.08 billion03/11/2025$109.30$105.79-3.21%$109.47$105.02171,290 shs$2.04 billion03/10/2025$114.83$109.30-4.82%$112.81$105.93130,643 shs$2.10 billion03/07/2025$116.00$114.83-1.01%$117.10$112.13119,540 shs$2.17 billion03/06/2025$115.41$116.00+0.51%$116.65$113.1487,397 shs$2.19 billion03/05/2025$115.26$115.41+0.13%$117.58$112.7299,779 shs$2.18 billion03/04/2025$112.18$115.26+2.75%$117.87$108.84128,500 shs$2.18 billion03/03/2025$122.23$112.18-8.22%$125.17$110.00164,247 shs$2.12 billion Related Companies RGEN Stock Chart HALO Stock Chart MDGL Stock Chart ALKS Stock Chart IONS Stock Chart FOLD Stock Chart DVAX Stock Chart BCRX Stock Chart MNKD Stock Chart CLDX Stock Chart Receive LGND Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Ligand Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:LGND) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredWall St. Icon: Looming Financial Tsunami Could Wipe Out the 1%Wall Street icon who forecasted Black Monday and dot-com crash says a new economic event could hit the America...InvestorPlace | SponsoredControversial opinion: Volume isn't enough.Don’t be fooled by volume alone — it's just one piece of the trading puzzle. High demand doesn’t matter if sup...MillPub | SponsoredRUTHLESS Musk Move >> coming June 1?Elon Musk has made headlines with everything from mass layoffs to political drama — but his next move could sh...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ligand Pharmaceuticals Incorporated Please log in to your account or sign up in order to add this asset to your watchlist. Share Ligand Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
